These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22014118)

  • 1. Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study.
    D'Aurizio E; Sozio P; Cerasa LS; Vacca M; Brunetti L; Orlando G; Chiavaroli A; Kok RJ; Hennink WE; Di Stefano A
    Mol Pharm; 2011 Dec; 8(6):2408-15. PubMed ID: 22014118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug.
    D'Aurizio E; van Nostrum CF; van Steenbergen MJ; Sozio P; Siepmann F; Siepmann J; Hennink WE; Di Stefano A
    Int J Pharm; 2011 May; 409(1-2):289-96. PubMed ID: 21356295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of rat striatal L-dopa and DA concentration after intraperitoneal administration of L-dopa prodrugs in liposomal formulations.
    Di Stefano A; Carafa M; Sozio P; Pinnen F; Braghiroli D; Orlando G; Cannazza G; Ricciutelli M; Marianecci C; Santucci E
    J Control Release; 2004 Sep; 99(2):293-300. PubMed ID: 15380638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties.
    Di Stefano A; Sozio P; Cocco A; Iannitelli A; Santucci E; Costa M; Pecci L; Nasuti C; Cantalamessa F; Pinnen F
    J Med Chem; 2006 Feb; 49(4):1486-93. PubMed ID: 16480285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS delivery of L-dopa by a new hybrid glutathione-methionine peptidomimetic prodrug.
    Pinnen F; Cacciatore I; Cornacchia C; Mollica A; Sozio P; Cerasa LS; Iannitelli A; Fontana A; Nasuti C; Di Stefano A
    Amino Acids; 2012 Jan; 42(1):261-9. PubMed ID: 21080012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing prodrugs for the treatment of Parkinson's disease.
    Sozio P; Cerasa LS; Abbadessa A; Di Stefano A
    Expert Opin Drug Discov; 2012 May; 7(5):385-406. PubMed ID: 22494466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP; Vavia PR
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanocarriers containing a levodopa prodrug with potential antiparkinsonian activity.
    Ravani L; Sarpietro MG; Esposito E; Di Stefano A; Sozio P; Calcagno M; Drechsler M; Contado C; Longo F; Giuffrida MC; Castelli F; Morari M; Cortesi R
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():294-300. PubMed ID: 25579926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
    Reza MS; Whateley TL
    J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro study of GDNF release from biodegradable PLGA microspheres.
    Aubert-Pouëssel A; Venier-Julienne MC; Clavreul A; Sergent M; Jollivet C; Montero-Menei CN; Garcion E; Bibby DC; Menei P; Benoit JP
    J Control Release; 2004 Mar; 95(3):463-75. PubMed ID: 15023458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
    Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
    Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa.
    Choudhary H; Agrawal AK; Malviya R; Yadav SK; Jaliwala YA; Patil UK
    Pharmazie; 2010 Mar; 65(3):194-8. PubMed ID: 20383939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in prodrug design for Parkinson's disease.
    Cacciatore I; Ciulla M; Marinelli L; Eusepi P; Di Stefano A
    Expert Opin Drug Discov; 2018 Apr; 13(4):295-305. PubMed ID: 29361853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats.
    Ren T; Yang X; Wu N; Cai Y; Liu Z; Yuan W
    Neurosci Lett; 2011 Sep; 502(2):117-22. PubMed ID: 21835223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa delivery systems: advancements in delivery of the gold standard.
    Ngwuluka N; Pillay V; Du Toit LC; Ndesendo V; Choonara Y; Modi G; Naidoo D
    Expert Opin Drug Deliv; 2010 Feb; 7(2):203-24. PubMed ID: 20095943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maleic- and fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation.
    Di Stefano A; Sozio P; Iannitelli A; Marianecci C; Santucci E; Carafa M
    J Drug Target; 2006 Nov; 14(9):652-61. PubMed ID: 17090401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and study of L-dopa-glutathione codrugs as new anti-Parkinson agents with free radical scavenging properties.
    Pinnen F; Cacciatore I; Cornacchia C; Sozio P; Iannitelli A; Costa M; Pecci L; Nasuti C; Cantalamessa F; Di Stefano A
    J Med Chem; 2007 May; 50(10):2506-15. PubMed ID: 17451233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.